Several red flags here. Studies and reagent development due for completion in 2019. I realise it's out of their control now, but clinical trial recruitment could be suspended indefinitely. And yet - still no communication from the company. This is extremely poor management. For those who have corresponded with the CEO, has there been any explanation why they are refusing to update the market ?
Lack of communication
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.92M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 95582 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 42876 | 1 |
View Market Depth
| Last trade - 10.08am 29/07/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable